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Surgical Glove Perforation and the Risk
of Surgical Site Infection
Heidi Misteli, MD; Walter P. Weber, MD; Stefan Reck, MD; Rachel Rosenthal, MD; Marcel Zwahlen, PhD;
Philipp Fueglistaler, MD; Martin K. Bolli, MD; Daniel Oertli, MD; Andreas F. Widmer, MD; Walter R. Marti, MD
Hypothesis: Clinically apparent surgical glove perfo-
ration increases the risk of surgical site infection (SSI).
Design: Prospective observational cohort study.
Setting: University Hospital Basel, with an average of
28 000 surgical interventions per year.
Participants: Consecutive series of 4147 surgical pro-
cedures performed in the Visceral Surgery, Vascular Sur-
gery, and Traumatology divisions of the Department of
General Surgery.
Main Outcome Measures: The outcome of interest
was SSI occurrence as assessed pursuant to the Centers
of Disease Control and Prevention standards. The pri-
mary predictor variable was compromised asepsis due to
glove perforation.
Results: The overall SSI rate was 4.5% (188 of 4147 pro-
cedures). Univariate logistic regression analysis showed
a higher likelihood of SSI in procedures in which gloves
were perforated compared with interventions with main-
tained asepsis (odds ratio [OR], 2.0; 95% confidence in-
terval [CI], 1.4-2.8; P .001). However, multivariate lo-
gistic regression analyses showed that the increase in SSI
risk with perforated gloves was different for procedures
with vs those without surgical antimicrobial prophy-
laxis (test for effect modification, P=.005). Without an-
timicrobial prophylaxis, glove perforation entailed sig-
nificantly higher odds of SSI compared with the reference
group with no breach of asepsis (adjusted OR, 4.2; 95%
CI, 1.7-10.8; P=.003). On the contrary, when surgical
antimicrobial prophylaxis was applied, the likelihood of
SSI was not significantly higher for operations in which
gloves were punctured (adjusted OR, 1.3; 95% CI, 0.9-
1.9; P=.26).
Conclusion: Without surgical antimicrobial prophy-
laxis, glove perforation increases the risk of SSI.
Arch Surg. 2009;144(6):553-558
D ESPITE THE SUBSTANTIALeffort deployed to main-tain asepsis during sur-gery, the risk of the trans-fer of pathogens remains.
Transfer mechanisms include, among oth-
ers, contact with the skin or blood. Patho-
gens may be transferred from the surgi-
cal staff to patients1,2 and vice versa.3,4 In
surgical settings, skin-borne pathogens on
staff hands are particularly susceptible to
transfer. Consequently, all surgical staff
members wear sterile gloves as a protec-
tive barrier to prevent hand-to-wound con-
tamination during operations. When
gloves are perforated, the barrier breaks
down and germs are transferred. With the
growing awareness among operating room
staff of their risk of exposure to disease
from patients, primarily human immuno-
deficiency virus and hepatitis B virus,5,6
gloves have begun to be regarded as a re-
quirement for their own protection. To-
day, surgical gloves must provide an ef-
fective germ barrier for both patients and
surgical staff.
The risk of perforation increases with the
duration of operating time—significantly so
after 2 hours7,8—and occurs more often
when gloves do not fit properly.9 The fac-
tors favoring glove perforation include, most
commonly, puncture by needles, spiked
bone fragments, or sharp surfaces on com-
plex instruments.10,11
The frequency of glove perforation dur-
ing surgery has been studied extensively
and found to range from 8% to 50%.7,9,12-16
The impact of glove perforation on the risk
of surgical site infection (SSI), however,
is unknown. The present study was con-
ducted to test the hypothesis that clini-
cally visible surgical glove perforation is
associated with an increased SSI risk.
METHODS
PATIENTS AND PROCEDURES
The data for this prospective observational study
were collected from January 1, 2000, through De-
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cember 31, 2001, at University Hospital Basel. The study was ap-
proved by the institutional review board as part of a broader qual-
ity improvement program, which was supported by the hospital
executive board. As an observational study, it was exempt from
the written informed consent requirement. All inpatient proce-
dures performed in the divisions of Vascular Surgery, Visceral Sur-
gery, and Traumatology of the Department of General Surgery
were consecutively enrolled. Operations requiring no incision (eg,
closed reductions of joint dislocations) were excluded, along with
procedures classified as wound class 4 (dirty infected) accord-
ing to the Centers for Disease Control and Prevention (CDC) cri-
teria.17 Such patients received perioperative and postoperative an-
timicrobial therapy, and it was assumed, moreover, that in these
cases the minimal bacterial transfer due to glove perforation might
be irrelevant in the context of such high rates of surgical site bac-
terial contamination.
OUTCOME OF INTEREST, PRIMARY PREDICTOR
VARIABLE, AND COVARIATES
The outcome of interest was the incidence of SSI, which was as-
sessed during the hospital stay by the surgical resident on a pro-
spective surveillance form. The attending surgeon cross-
checkedeach formpursuant toCDCstandards.17 Threeapproaches
were used for postdischarge monitoring. The forms and supple-
mentary documents, along with a description of the quality con-
trol strategy, were sent to the primary care practitioners conduct-
ing postsurgery clinical controls. As many as 2 reminders were
sent, emphasizing the need to fully ascertain the presence of SSI.
The second step consisted of screening all patients’ medical rec-
ords to identify readmissions and outpatient visits to University
Hospital Basel. The forms for most patients in the Division of Trau-
matology were completed on the occasion of such routine visits.
When the first 2 steps for postdischarge follow-up could not be
performed, 1 of the physicians on the study team (H.M., W.P.W.,
S.R., R.R., or P.F.) interviewed the patients by telephone, using a
standardized questionnaire. All incidents of SSI were validated
by a board-certified infectious disease specialist (A.F.W.), on the
basis of a comprehensive review of the patient history, initial mi-
crobiology results, and outcome at least 30 days after surgery when
no implants were involved or more than 1 year after surgery if
an implant was in place.
The main predictor variable was compromised asepsis due
to glove perforation. The use of single gloves was standard prac-
tice, whereas double gloving was left to the surgeon’s discre-
tion in each procedure and depended on the surgeon’s assess-
ment of the risk of glove perforation. The operating room nurse
was responsible for detecting and recording breaches of asep-
sis, directly when perforation/leakage was obvious or indi-
rectly when liquid was visible inside a glove. When double gloves
were used, perforation/leakage of the inner glove was re-
corded. The gloves used included a powder-free latex surgical
glove with a thin inner coating of acrylate terpolymer (gauge,
0.27 mm at the cuff and 0.15 mm at the tip of the index finger)
(Biogel; Regent Hospital Products, Mölnlyche Health Care, Ku-
lim, Malaysia); a powdered latex surgical glove (gauge, 0.205
mm at the palm and 0.235 mm at the tip of the middle finger)
(Gammex; Ansell Healthcare Europe NV, Munich, Germany);
and another powder-free latex surgical glove (gauge, 0.205 mm
at the palm and 0.22 mm at the tip of the middle finger) (Nu-
tex; Ansell Healthcare Europe NV).
A total of 82 patient and procedural characteristics were pro-
spectively recorded and included age, sex, underlying disease,
additional diagnoses, American Society of Anesthesiologists
score, type of procedure, division of surgical specialty, CDC
wound class, and duration of surgery. The data were entered
on an electronically readable 4-page data sheet created by com-
mercially available software (Cardiff TELEForm Desktop, ver-
sion 8.0; Verity Incorporated, Sunnyvale, California).18 Miss-
ing data were reviewed and completed as necessary with data
from the respective medical histories. Each completed form was
cross-checked by a second member of the research team (H.M.,
W.P.W., S.R., R.R., or P.F.).
SURGICAL ANTIMICROBIAL PROPHYLAXIS
Prophylactic antimicrobial administration was standardized to
the CDC guidelines.17 Patients received antimicrobial prophy-
laxis if they underwent surgery classified as CDC wound classes
3 (contaminated), 2 (clean contaminated), and 1 (clean) in-
volving a nonabsorbable implant or, at the discretion of the sur-
geon, any clean operation in which a subsequent SSI would have
posed high risk to the patient. Antimicrobial prophylaxis, which
was regarded to be perioperative for no longer than 24 hours,
consisted of a single intravenous infusion of 1.5 g of cefurox-
ime sodium, in conjunction with 500 mg of metronidazole phos-
phate in colorectal surgery. Pursuant to our internal hospital
guidelines, this dose was readministered at 4-hour intervals
through the end of the procedure. In fractured bone osteosyn-
thesis, prophylaxis lasted for 24 hours, with injection of 0.75
g of cefuroxime sodium 8 and 16 hours after the first dose.
STATISTICAL ANALYSIS
For data description we calculated frequencies of surgical pro-
cedures according to patient and procedure characteristics, and
we used the 2 test to assess difference in the distributions be-
tween procedures with and without glove perforation. To as-
sess the association of SSI with characteristics of the patient and
surgical procedure, we fitted logistic regression models. The
simplest models included only an indicator variable for glove
perforation and an indicator for use of antimicrobial prophy-
laxis. Adjusted models included the sex and age of the patient,
the CDC wound class (3 classes), the duration of surgery, the
number of operations that surpassed the T time (the 75th per-
centile [in hours] of the duration of surgery as defined in the
National Nosocomial Infections Surveillance System),19 and the
American Society of Anesthesiologists score (4 groups). To test
for the effect modification between glove perforation and the
use of antimicrobial prophylaxis, an interaction term was in-
cluded in the adjusted model. Because this effect modification
was statistically significant, separate logistic regression mod-
els were fitted for procedures with and without the use of an-
timicrobial prophylaxis. In these separate analyses, glove per-
foration was the main predictor variable of interest.
All P values are 2 sided, and all analyses were performed
using Stata statistical software, version 9 (StataCorp, College
Station, Texas).
RESULTS
From January 1, 2000, through December 31, 2001, a total
of 6540 inpatient invasive procedures were performed
in the Department of General Surgery at University Hos-
pital Basel. Full in-hospital data records were created for
6283 procedures (96.1%) performed on 4808 patients.
A long-term follow-up data set was built for 5721 of these
6283 procedures (91.1%). In 4768 of the 5721 proce-
dures (83.3%), follow-up was performed by a physi-
cian, and the remaining 953 patients (16.7%) were sur-
veyed by telephone. Seven hundred forty-seven
procedures of the 6283 procedures (11.9%) were ex-
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cluded owing to CDC class 4 surgical wounds. In 1389
cases (22.1%), the state of asepsis during surgery was not
prospectively recorded. The remaining 4147 proce-
dures (66.0%) were accepted for further analysis. The
main characteristics of these surgical interventions are
summarized in the Table.
A total of 188 instances of SSI (4.5%) were detected
in the 4147 procedures studied. We classified SSI as fol-
lows: superficial (n=56), deep (n=62), and organ/space
(n=70). Asepsis was compromised by glove leakage in
677 interventions (16.3%) and maintained in the remain-
ing 3470 (83.7%).
In the 677 procedures with compromised asepsis, 51
instances (7.5%) of SSI were recorded, compared with
137 instances in 3470 procedures (3.9%) when asepsis
was not breached (crude odds ratio [OR], 2.0; 95% con-
fidence interval [CI], 1.4-2.8; P .001). Gloves were per-
forated in 398 of the 1171 procedures (34.0%) that lasted
longer than 2 hours, compared with only 279 of 2976
(9.4%) that lasted 2 hours or less.
Multivariate logistic regression analyses showed that
the increase in the SSI risk with perforated gloves was
different for procedures with vs those without antimi-
crobial prophylaxis (test for effect modification, P=.005).
We therefore analyzed the risk association separately for
glove perforations in surgeries with and without antimi-
crobial prophylaxis. Surgical antimicrobial prophylaxis
was applied in 3233 interventions; glove perforations were
detected in 605 of these operations (18.7%).
In the presence of surgical antimicrobial prophy-
laxis, the rate of SSI (6.9% vs 4.3%; crude OR, 1.7; 95%
CI, 1.2-2.4; P=.007) was higher in procedures involv-
ing perforated gloves compared with procedures with
maintained intraoperative asepsis. After adjusting for 6
confounders in multivariate logistic regression analysis,
however, the odds of contracting SSI in the event of glove
puncture were not significantly higher when compared
with procedures with intact gloves (adjusted OR, 1.3; 95%
CI, 0.9-1.9; P=.26) (Figure 1).
In the absence of surgical antimicrobial prophylaxis
(n=914), glove leakage was associated with an SSI rate
of 12.7%, as opposed to 2.9% when asepsis was not
breached (Figure 2). This difference proved to be sta-
tistically significant when assessed with both univariate
(OR, 4.9; 95% CI, 2.2-11.0; P .001) and multivariate
(OR, 4.2; 95% CI, 1.7-10.8; P=.003) analyses.
The risk of developing SSI is therefore significantly
higher in surgical procedures in which gloves are perfo-
rated and no antimicrobial prophylaxis is administered.
COMMENT
As early as 1915, Brewer20 studied the impact of asepsis
on the risk of SSI and reported that rigorous observa-
Table. Patient and Procedure Characteristics and
Incidence of SSI by Glove Integrity
Characteristic
No. (%) of Interventionsa
P Value
With
Perforated
Gloves
With Intact
Gloves
Total 677 (100.0) 3470 (100.0) .001
SSIs 51 (7.5) 137 (3.9) .001
Surgical antimicrobial
prophylaxis
.006
Yes 605 (89.4) 2628 (75.7)
No 72 (10.6) 842 (24.3)
Sex .001
Female 292 (43.1) 1791 (51.6)
Male 385 (56.9) 1679 (48.4)
Age, y .40
30 56 (8.3) 284 (8.2)
30-39 69 (10.2) 421 (12.1)
40-49 89 (13.2) 490 (14.1)
50-59 103 (15.2) 560 (16.1)
60-69 137 (20.2) 597 (17.2)
70-79 123 (18.2) 607 (17.5)
80-89 87 (12.9) 417 (12.0)
90 13 (1.9) 94 (2.7)
Division .85
Visceral surgery 285 (42.1) 1501 (43.3)
Traumatology 273 (40.3) 1377 (39.7)
Vascular surgery 119 (17.6) 592 (17.1)
ASA score .001
I 75 (11.1) 512 (14.8)
II 281 (41.5) 1704 (49.1)
III 263 (38.8) 1112 (32.0)
IV 53 (7.8) 140 (4.0)
V 5 (0.7) 2 (0.1)
Wound class (class No.) .51
Clean (1) 459 (67.8) 2372 (68.4)
Clean contaminated (2) 133 (19.6) 625 (18.0)
Contaminated (3) 85 (12.6) 473 (13.6)
T time exceeded .001
Yes 286 (42.2) 553 (15.9)
No 391 (57.8) 2917 (84.1)
Duration of surgery, h .001
2 279 (41.2) 2697 (77.7)
2 398 (58.8) 773 (22.3)
Abbreviations: ASA, American Society of Anesthesiologists; SSI, surgical
site infection; T time, 75th percentile (in hours) of the duration of surgery as
defined in the National Nosocomial Infections Surveillance System.19
aPercentages have been rounded and may not total 100.
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Figure 1. Crude and adjusted odds ratios and 95% confidence intervals for
the association of surgical site infection with glove perforation (yes vs no)
stratified for use of antimicrobial prophylaxis. Variables included in the
adjusted models were wound class, the duration of surgery, the number of
operations that surpassed the T time (75th percentile [in hours] of the
duration of surgery as defined in the National Nosocomial Infections
Surveillance System), the American Society of Anesthesiologists score, and
patient age and sex.
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tion of surgical staff’s aseptic practices could reduce the
rate of SSI in clean wounds. He concluded that a height-
ened awareness of the importance of asepsis and more
effective teamwork in the creation of a low-risk environ-
ment5 could therefore reduce the risk of SSI. Today, strict
rules are in place to maintain asepsis in all types of sur-
gical interventions. Despite the precautions taken to pre-
vent glove perforation, the risk of such accidents is still
relevant. Several studies have addressed the frequency
of breaks in the glove barrier.7,9,12-16 Little information is
available, however, on the association between glove per-
foration and SSI risk. Al-Habdan et al21 detected only 3
instances of SSI related to punctured gloves in 150 pro-
cedures. Although 2 reports have been published on ran-
domized trials conducted to analyze glove perforation as
a primary predictor,22,23 neither reported the SSI assess-
ment method used, and not a single SSI was found in
either. To our knowledge, this is the first study to ex-
plore the correlation between SSI and glove leakage in a
large series of surgical procedures. The results clearly show
that, in the absence of surgical antimicrobial prophy-
laxis, there is a significant correlation between clini-
cally visible glove perforation and the occurrence of SSI.
The most effective method for lowering the fre-
quency of leakage is double gloving, which reduces glove
failure significantly from rates as high as 51% with single
gloves to as low as 7% of inner glove puncture when 2
pairs are used.15,24-26 Furthermore, inner glove perfora-
tion rates are proving to be significantly lower with the
use of indicator gloves (colored latex undergloves to alert
operators to perforations) than with the conventional va-
riety.16,27,28 Irrespective of possible precautions, how-
ever, the risk of glove perforation continues to be a clini-
cal problem.21,29,30 Latex is more resistant than vinyl, for
instance, and provides better protection against infec-
tion.31 In the present study, only latex gloves were used,
with the exception of surgical staff members with a docu-
mented latex allergy.
Another way to lower the risk of glove perforation is
to routinely replace gloves after a specified period of time.
A standard cutoff time would be 2 hours because the over-
all risk of glove puncture has been reported to rise sig-
nificantly in procedures lasting more than 2 hours.7 Such
reports and the recommendation to change gloves
regularly during long operations are consistent with the
present data, which show that the duration of surgery
directly affects the incidence of perforations.
The use of surgical microbial prophylaxis is still con-
troversial. Several randomized controlled trials and ob-
servational studies have addressed the efficacy of differ-
ent antimicrobial agents for patients undergoing breast
surgery, hernia repair, and neurosurgery.32-42 Most of these
studies showed significantly lower SSI rates in patients
receiving prophylaxis,32-37,42 and many hospitals there-
fore require the use of perioperative antibiotics for all
wound classes. However, the incidence of SSI after clean
surgical procedures traditionally has been regarded as too
low for routine antimicrobial prophylaxis. Current CDC
guidelines recommend a restricted use of antibiotics and
are supported by studies that failed to demonstrate that
prophylactic antimicrobials significantly reduce the in-
cidence of SSI after clean procedures.38-41 Indications for
prophylactic antimicrobials approved by the CDC are
clean operations involving prosthetic material and any
operation in which a potential SSI would pose cata-
strophic risk.17 Examples are all cardiac operations, most
neurosurgical and major vascular operations, and some
operations on the breast. A 2006 Cochrane meta-
analysis43 concluded that prophylactic antimicrobials re-
duce the risk of SSI in patients undergoing surgery for
breast cancer. In these patients, the presence of an in-
fected breast wound delays the beginning of adjuvant an-
ticancer therapy, and surgical antimicrobial prophy-
laxis seems justified. Our series of 1917 clean procedures
with prophylactic antimicrobials involved trauma in 1219
procedures (63.6%), mesh hernia in 292 (15.2%), the
breast in 109 (5.7%), and vascular operations in 297
(15.5%).
Our study had several limitations. First, 22.1% of the
information on glove perforation was missing. Nonethe-
less, the 1389 procedures involved did not appear to bias
the results because the SSI rate did not differ signifi-
cantly from the rate found for the study population (4.9%
vs 4.5%; P=.58). Second, because this was a prospective
observational study rather than a randomized con-
trolled trial, a number of characteristics, such as the T
time, the duration of surgery, the American Society of
Anesthesiologists scores I through V, and patient sex dif-
fered significantly between study groups. However, the
distribution of other patient and procedure characteris-
tics (age, division of surgical specialty, and, most impor-
tantly, wound classes 1 through 3) did not differ signifi-
cantly between the study groups. To adjust the results
where appropriate, all characteristics exhibiting signifi-
cant misdistribution were included in the multivariate
analysis. That notwithstanding, residual confounding by
unknowns can never be ruled out entirely in observa-
tional studies. The study was further limited by the non-
validated techniques used to detect glove leakage. In many
studies, gloves are tested by air insufflations after use to
detect even minor uncontrolled perforations. Inasmuch
as the study hypothesis focused on the implications for
SSI, detection was restricted to the macroscopic evi-
dence of punctures during surgery or the visible effu-
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Figure 2. Rate of surgical site infections (SSIs) in 4147 surgical procedures
by use of surgical antimicrobial prophylaxis and maintenance of
intraoperative asepsis.
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sion of fluid inside the glove, which may cause a more sub-
stantial transfer of germs. Finally, because this study was
conducted from 2000 to 2001, one might debate that sig-
nificant changes in circulating relevant bacteria (eg, meth-
icillin-resistant Staphylococcus aureus) could diminish the
current value of these data. Since 1994, however, the Di-
vision of Infectious Disease and Hospital Epidemiology at
University Hospital Basel routinely performs ongoing full-
house surveillance of bloodstream infections and com-
piles yearly statistics of microbiological results. All strains
of emerging pathogens, methicillin-resistantSaureus, gram-
negative pathogens expressing broad-spectrum betalacta-
mases, and multiresistantPseudomonas aeruginosa andAci-
netobacter are saved and stored at −70°C and routinely typed
by means of pulsed-field electrophoresis, polymerase chain
reaction analysis, spa typing (DNA sequence analysis of the
protein A gene variable repeat region), or multilocus se-
quencing as appropriate. The distribution of pathogens and
the resistance pattern basically remained unchanged dur-
ing the past decade, despite quite different trends in other
hospitals. The incidence of methicillin-resistant S aureus
is stable at a very low rate of 0.14 to 0.17 per 1000 patient
days, or approximately 1% of all S aureus infections.44 The
only changes recorded are an increase in pathogens ex-
pressing broad-spectrum betalactamases in the outpatient
clinics and an increase in Clostridium difficile–associated
diarrhea.45
CONCLUSIONS
Although many authors have studied the frequency of
glove perforation, the clinical consequences in terms of
SSI have been largely neglected. The present study shows
that, in the absence of surgical antimicrobial prophy-
laxis, glove perforation is a risk factor for SSI. Efforts to
decrease the frequency of glove perforation, such as double
gloving and the routine changing of gloves during lengthy
surgical procedures, are therefore encouraged. These mea-
sures are effective and safe. However, implementing them
in clinical practice can be difficult. Although surgical an-
timicrobial prophylaxis has been demonstrated to pre-
vent SSI after clean surgery in several randomized con-
trolled trials,32,34-37,42 there is no current consensus
regarding its use in this area. The present results sup-
port an extended indication of surgical antimicrobial pro-
phylaxis to all clean procedures in the absence of strict
precautions taken to prevent glove perforation. The ad-
vantages of this SSI prevention strategy, however, must
be balanced against the costs and adverse effects of the
prophylactic antimicrobials, such as drug reactions or in-
creased bacterial resistance.
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INVITED CRITIQUE
T his 2-year study by Misteli and colleagues relatesSSI to the incidence of surgical glove perforationin more than 4100 general surgery patients. Glove
perforation occurred in 16.3% of cases and rose dramati-
cally in cases lasting longer than 2 hours (34.0% vs 9.4%).
Surgical site infection was identified in 7.5% of the cases
in which there was a glove perforation vs 3.9% when there
was none. The essence of the study resides in the multi-
variate logistic regression analysis, by which glove perfo-
ration was found to be a significant risk factor for SSI but
only in cases in which prophylactic antibiotics were not
used.
Although the authors handled the limitations of this
study nicely, a few issues persist:
v Nearly70%ofthecases(n=2831)wereclass1(clean),
yetantibioticprophylaxiswaswithheldinonly914(32.3%)
of the class 1 cases. This implies that the other two-thirds
of class 1 cases had a nonabsorbable implant or involved
a patient for whom SSI posed a “high risk.” The specific
factors guiding the surgeons’ decision regarding antibi-
otic prophylaxis in this group would be useful to know.
v I do not believe the recommendation to extend an-
tibiotic prophylaxis guidelines is justified. The recom-
mendation is based on 9 or 10 patients of the 72 with-
out antibiotic prophylaxis whose surgeon had a perforated
glove and who went on to develop an SSI. Although the
risk of SSI (with vs without glove perforation) among pa-
tients without antibiotic prophylaxis was significant on
multivariate analysis, the data in this and other studies
cited by the authors much more strongly support the mea-
sures suggested for lowering the risk of glove perfora-
tion. These measures would be substantially cheaper, more
promising for efficacy, and less likely to produce aller-
gies or adverse effects than giving prophylactic antibi-
otics to all patients.
Correspondence: Dr Cornwell, Department of Surgery,
Howard University Hospital, 2041 Georgia Ave NW, Ste
4B02, Washington, DC 20060 (ecornwell@howard
.edu).
Financial Disclosure: None reported.
Edward E. Cornwell III, MD
(REPRINTED) ARCH SURG/ VOL 144 (NO. 6), JUNE 2009 WWW.ARCHSURG.COM
558
©2009 American Medical Association. All rights reserved.
 at University of Basel, on June 17, 2009 www.archsurg.comDownloaded from 
